Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

被引:47
作者
Shi, Ming [1 ]
Chen, Ji-An [1 ]
Lin, Xiao-Jun [1 ]
Guo, Rong-Ping [1 ]
Yuan, Yun-Fei [1 ]
Chen, Min-Shan [1 ]
Zhang, Ya-Qi [1 ]
Li, Jin-Qing [1 ]
机构
[1] Sun Yat Sen Univ, Dept Hepatobiliary, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Palliative treatment; Prognosis; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED TRIAL; PROGNOSTIC-FACTORS; NATURAL-HISTORY; LIVER-CANCER; MANAGEMENT; SURVIVAL; COHORT; EMBOLIZATION; CIRRHOSIS;
D O I
10.3748/wjg.v16.i2.264
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To identify prognostic factors from pretreatment variables of the initial transarterial chemoembolization (TACE) procedure in unresectable hepatocellular carcinoma (HCC). METHODS: One thousand and five hundred and sixty-nine patients with unresectable HCC underwent TACE as initial treatment were retrospectively studied. Pretreatment variables of the initial TACE procedure with a P value less than 0.05 by univariate analysis were subjected to Cox proportional hazards model. RESULTS: The median overall survival time and 1-, 5-, 10-year survival rates were 10.37 mo, 47%, 10%, and 7%, respectively. A Cox proportional hazard model showed that 8 pretreatment factors of regional lymph nodes metastasis, Child-Pugh class, macrovascular invasion, greatest dimension, alpha-fetoprotein (AFP), Hepatitis virus B, tumor capsule, and nodules were independent prognostic factors. Patients with multimodality therapy have better survival than those with TACE treatment only. CONCLUSION: Tumor status, hepatic function reserve, AFP, and hepatitis virus B status were independent prognostic factors for unresectable HCC. Distant metastasis might not be a contraindication to TACE. Multimodality therapy might improve survival. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 30 条
[21]   Global cancer statistics, 2002 [J].
Parkin, DM ;
Bray, F ;
Ferlay, J ;
Pisani, P .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) :74-108
[22]   The global health burden of infection -associated cancers in the year 2002 [J].
Parkin, Donald Maxwell .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (12) :3030-3044
[23]   Natural history of untreated primary hepatocellular carcinoma - A retrospective study of 157 patients [J].
Pawarode, A ;
Voravud, N ;
Sriuranpong, V ;
Kullavanijaya, P ;
Patt, YZ .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04) :386-391
[24]   Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with child's grade A or B cirrhosis - A multivariate analysis of prognostic factors [J].
Savastano, S ;
Miotto, D ;
Casarrubea, G ;
Teso, S ;
Chiesura-Corona, M ;
Feltrin, GP .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1999, 28 (04) :334-340
[25]   Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients [J].
Takayasu, Kenichi ;
Arii, Shigeki ;
Ikai, Iwao ;
Omata, Masao ;
Okita, Kiwamu ;
Ichida, Takafumi ;
Matsuyama, Yutaka ;
Nakanuma, Yasuni ;
Kojiro, Masamichi ;
Makuuchi, Masatoshi ;
Yamaoka, Yoshio .
GASTROENTEROLOGY, 2006, 131 (02) :461-469
[26]  
Ueno K, 2000, CANCER, V88, P1574, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1574::AID-CNCR11>3.0.CO
[27]  
2-8
[28]  
Wigmore SJ, 2004, EUR J SURG ONCOL, V30, P41, DOI 10.1016/j.ejso.2003.10.007
[29]   Natural history of untreated nonsurgical hepatocellular carcinoma [J].
Yeung, YP ;
Lo, CM ;
Liu, CL ;
Wong, BC ;
Fan, ST ;
Wong, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09) :1995-2004
[30]   Prognostic analysis of pulmonary metastases from hepatocellular carcinoma [J].
Zhang, Shu-Min ;
Zeng, Zhao-Chong ;
Tang, Zhao-You ;
Sun, Jing ;
Cheng, Jie-Min ;
Liu, Rong ;
Wang, Ping ;
Zhang, Bo-Heng .
HEPATOLOGY INTERNATIONAL, 2008, 2 (02) :237-243